The Johns Hopkins Hospital
600 N. Wolfe Street
Maumenee Suite 746
Baltimore, MD 21287
Diabetic Retinopathy, Macular Degeneration, Age-Related, Ophthalmology, Retina, Surgical Diseases
Angiogenesis; Gene Therapy; Diabetic Retinopathy; Macular Degeneration; microsurgical instrument development
Peter Gehlbach, M.D., Ph.D., has been a member of the Wilmer faculty since 2000 and holds a faculty appointment in the Whitaker Biomedical Engineering Institute. He was recruited by a national search to become the inaugural Maumenee Scholar at Johns Hopkins University School of Medicine. Dr. Gehlbach is an expert in the medical and surgical care of vitreoretinal diseases. His clinical practice is composed of international, national and regional patient populations with the most complex retinal disease. An expert vitreoretinal surgeon, Dr. Gehlbach has been a leader in performing and teaching complex surgical cases that require coordination with multiple ophthalmological specialists. His research interests include cutting-edge approaches to patients with surgical disease and the development of novel surgical tools and approaches to retinal microsurgery.
Dr. Gehlbach's work has been supported by multiple NIH grants as well as prestigious foundations. His research has been published in numerous peer-reviewed journals and has been presented at ophthalmology conferences around the world. He holds a number of patents in both the U.S. and abroad. He is the founding director of the former Wilmer Gene Therapy Vector Center and now serves as the director of the Wilmer Echography Center. He holds a Governor's Appointment in the State of Maryland as a member of the Board of Trustees of Blind Industries and Services of Maryland.
Dr. Gehlbach received his M.D. degree from the University of Vermont and his Ph.D. in cell and integrative physiology from the University of Minnesota. He completed an internship and residency in general surgery at the University of Health Sciences, Chicago Medical School and his ophthalmology residency at Washington University, where he also completed a fellowship in protein chemistry. He completed a retina fellowship at the Casey Eye Institute in Portland, Oregon.